Tag: Challenges of EU Joint Clinical Assessment

  • Drug Value with RWE and Role of AI in EU’s JCA

    Drug Value with RWE and Role of AI in EU’s JCA

    —

    by

    wlcus_admin
    in

    Drug Value with Real-World Evidence (RWE): Opportunities, Challenges, and the Role of AI in EU’s Joint Clinical Assessment (JCA) What is Real-World Evidence and Why It Matters in the EU HTA Landscape Real-World Evidence (RWE) refers to health data gathered outside of traditional clinical trials. It comes from sources like electronic health records, patient registries,…